These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27899010)

  • 1. New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA.
    Pisetsky DS; Rovin BH; Lipsky PE
    Arthritis Rheumatol; 2017 Mar; 69(3):487-493. PubMed ID: 27899010
    [No Abstract]   [Full Text] [Related]  

  • 2. The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al.
    Major GA
    Arthritis Rheum; 2011 Apr; 63(4):1157-8; author reply 1158. PubMed ID: 21452333
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis.
    Maloney KC; Ferguson TS; Stewart HD; Myers AA; De Ceulaer K
    Lupus; 2017 Nov; 26(13):1448-1456. PubMed ID: 28480787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.
    Infantino M; Grossi V; Benucci M; Li Gobbi F; Damiani A; Manfredi M
    Lupus; 2018 Jan; 27(1):40-48. PubMed ID: 28587585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal?
    Nossent HC; Rekvig OP
    Arthritis Res Ther; 2005; 7(2):85-7. PubMed ID: 15743494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies.
    Fredi M; Cavazzana I; Zanola A; Carabellese N; Tincani A; Mahler M; Franceschini F
    Lupus; 2017 Sep; 26(10):1121-1122. PubMed ID: 28420064
    [No Abstract]   [Full Text] [Related]  

  • 7. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
    Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
    Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythmatosus - When to consider and management options.
    Apostolopoulos D; Hoi AY
    Aust Fam Physician; 2013 Oct; 42(10):696-700. PubMed ID: 24130970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
    Tiao J; Feng R; Carr K; Okawa J; Werth VP
    J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood hermolytic uremic syndrome associated with systemic lupus erythematosus.
    Wu CY; Su YT; Wang JS; Chiou YH
    Lupus; 2007; 16(12):1006-10. PubMed ID: 18042599
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of anti-DNA auto-antibodies as biomarkers of response to treatment in systemic lupus erythematosus patients: hypes and hopes. Insights and implications from a comprehensive review of the literature.
    Bragazzi NL; Watad A; Damiani G; Adawi M; Amital H; Shoenfeld Y
    Expert Rev Mol Diagn; 2019 Nov; 19(11):969-978. PubMed ID: 31516059
    [No Abstract]   [Full Text] [Related]  

  • 12. Chylothorax as the initial presentation of systemic lupus erythematosus: a case report.
    Lin YJ; Chen DY; Lan JL; Hsieh TY
    Clin Rheumatol; 2007 Aug; 26(8):1373-4. PubMed ID: 16927041
    [No Abstract]   [Full Text] [Related]  

  • 13. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
    van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
    Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
    [No Abstract]   [Full Text] [Related]  

  • 14. [The new classification criteria for systemic lupus erythematosus (SLICC)].
    Costedoat-Chalumeau N; Francès C; Pouchot J; Piette JC
    Rev Med Interne; 2014 Aug; 35(8):487-90. PubMed ID: 24467799
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to dsDNA in drug induced lupus erythematosus.
    Cohen MG
    J Rheumatol; 1994 Mar; 21(3):578-9. PubMed ID: 8006909
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological analysis of 16 antinuclear antibodies in disseminated lupus erythematosus].
    Boulila Elgaied A; Hintati B; Fakhfakh F; Karray H; Hachicha J; Jarraya A; Ayadi H
    Tunis Med; 1993 Feb; 71(2):91-5. PubMed ID: 8322428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systemic lupus erythematosus with anti-centromere antibodies: An infrequent finding without scleroderma related features].
    Cabrera CM
    Med Clin (Barc); 2016 Oct; 147(7):322-4. PubMed ID: 26832202
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crossing of antinuclear antibodies and anti-leishmania antibodies.
    Granel B; Serratrice J; Swiader L; Gambarelli F; Daniel L; Fossat C; Hesse-Bonérandi S; Pache X; Disdier P; Weiller PJ
    Lupus; 2000; 9(7):548-50. PubMed ID: 11035423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.